Leadership

{{leaderDetail.name}}

CEO

Dr. Zhou was a practicing physician before he started his career in industry. He has expertise in all stages of monoclonal antibody drug development, from antibody construction and evaluation to clinical phase studies. He was CEO of a Shanghai-based biotech company. He supervised dozens of projects and has seen CFDA approval of Certificate for Trial Application (CTA) for over 10 molecules.